Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.
We tested the hypothesis that the actions of Angiotensin (Ang)-(1-7) in the heart could involve changes in tissue levels of Ang II. This possibility was addressed by determining the effect of chronic infusion of Ang-(1-7) on plasma and tissue angiotensins. Ang-(1-7) was infused subcutaneously (osmotic minipumps) in Wistar rats. Angiotensins were determined by radioimmunoassay (RIA) in plasma, heart, and kidney. Tissue and plasma angiotensin-converting enzyme (ACE) activity and plasma renin activity (PRA) were also measured. Cardiac and renal ACE2 mRNA levels and cardiac angiotensinogen mRNA levels were assessed by semi-quantitative polymerase chain reaction (PCR). AT1 receptor number was evaluated by autoradiograph. Chronic infusion of Ang-(1-7) (2 microg/h, 6 days) produced a marked decrease of Ang II levels in the heart. A less pronounced but significant decrease of Ang-(1-7) was also observed. No significant changes were observed for Ang I. Ang II was not altered in the kidney. In this tissue, a significant increase of Ang-(1-7) and Ang I concentration was observed. A significant increase of plasma Ang-(1-7) and Ang II was also observed. Ang-(1-7) infusion did not change ACE activity or PRA. A selective slight significant increase in ACE2 expression in the heart was observed. Heart angiotensinogen mRNA as well as the number of Ang II binding sites did not change. These results suggest that AT1 receptors-independent changes in heart Ang II concentration might contribute for the beneficial effects of Ang-(1-7) in the heart. Moreover, these results reinforce the hypothesis that this angiotensin plays an important site-specific role within the renin-angiotensin system.
Mendes
Ana Cristina R
AC
Department of Physiology and Biophysics, Biological Sciences Institute, Federal University of Minas Gerais, 31 270-901, Belo Horizonte, MG, Brazil.
Ferreira
Anderson J
AJ
Pinheiro
Sérgio V B
SV
Santos
Robson A S
RA
D000803:Angiotensin I / Q000494:pharmacology*; D000804:Angiotensin II / Q000096:biosynthesis*; D000818:Animals; D002118:Calcium / Q000737:chemistry; D017931:DNA Primers / Q000737:chemistry; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010446:Peptide Fragments / Q000494:pharmacology*; D010455:Peptides / Q000737:chemistry; D016133:Polymerase Chain Reaction; D017434:Protein Structure, Tertiary; D012333:RNA, Messenger / Q000378:metabolism; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D012084:Renin-Angiotensin System; D013997:Time Factors
D017931:DNA Primers; D010446:Peptide Fragments; D010455:Peptides; D012333:RNA, Messenger; D000804:Angiotensin II; D000803:Angiotensin I; C118790:angiotensin I (1-7); D002118:Calcium